Brief: Gubra Announces Collaboration With Amylyx Pharmaceuticals

Gubra A/S

30/12/2024 12:31

Dec 30 (Reuters) - Gubra A/S  GUBRA.CO :
    * ANNOUNCES NEW COLLABORATION WITH AMYLYX PHARMACEUTICALS
    * COLLABORATION TO DEVELOP NOVEL LONG-ACTING GLP-1 RECEPTOR
ANTAGONIST
    * WILL RECEIVE UPFRONT AND RESEARCH PAYMENTS
    * MAY RECEIVE OVER $50 MILLION IN SUCCESS-BASED DEVELOPMENT,
COMMERCIALIZATION MILESTONES PLUS MID-SINGLE DIGIT ROYALTIES ON
WORLDWIDE NET SALES

Source text:  ID:nMFN4Z1fQy 
Further company coverage:  GUBRA.CO 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))